Liposomal Alpha-Galactosylceramide Ameliorates Graft-Versus-Host Disease with Remaining Intensified GVL Gained By Dose-Reduction of Posttransplant Cyclophosphamaide after Haploidentical HSCT
- Resource Type
- Abstract
- Source
- In
Blood 8 December 2017 130 Supplement 1:1897-1897 - Subject
- Language
- ISSN
- 0006-4971